Page last updated: 2024-11-07

pitofenone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Pitofenone is a synthetic compound with a ketone functional group. It exhibits potent anticonvulsant properties and has been explored as a potential therapeutic agent for epilepsy. Pitofenone has a complex mechanism of action, involving modulation of GABAergic neurotransmission and inhibition of neuronal hyperexcitability. However, due to its significant cardiovascular side effects, its clinical development for epilepsy treatment has been discontinued.'

pitofenone: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID121098
CHEMBL ID2104821
CHEBI ID135547
SCHEMBL ID2111794
MeSH IDM0064715

Synonyms (26)

Synonym
CHEBI:135547
pitofenone
54063-52-4
methyl o-(p-(2-piperidinoethoxy)benzoyl)benzoate
methyl 2-[4-(2-piperidin-1-ylethoxy)benzoyl]benzoate
pitofenona
pitofenona [inn-spanish]
m09n8k7yjy ,
unii-m09n8k7yjy
pitofenone [inn:dcf]
pitofenonum
pitofenonum [inn-latin]
CHEMBL2104821
methyl 2-({4-[2-(piperidin-1-yl)ethoxy]phenyl}carbonyl)benzoate
STL484040
pitofenone [inn]
pitofenone [who-dd]
pitofenonehcl
DTXSID6048381
SCHEMBL2111794
pitofenone-d4 (deuterated)
AKOS025149152
benzoic acid, 2-[4-[2-(1-piperidinyl)ethoxy]benzoyl]-, methyl ester
A914549
FT-0700592
Q7199015

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"A new HPLC method for separation and determination of impurities in paracetamol, codeine phosphate hemihydrate and pitophenone hydrochloride in the presence of fenpiverinium bromide in combined suppository dosage form was developed and validated."( Separation and determination of impurities in paracetamol, codeine and pitophenone in the presence of fenpiverinium in combined suppository dosage form.
Coufal, P; Hanzlík, P; Jedlička, A; Vojta, J, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
benzophenonesAny aromatic ketone in which the carbonyl group is bonded to 2 phenyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
gemininHomo sapiens (human)Potency16.78890.004611.374133.4983AID624296
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (20.00)18.7374
1990's4 (40.00)18.2507
2000's1 (10.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 48.75

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index48.75 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.95 (4.65)
Search Engine Demand Index70.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (48.75)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (27.27%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (72.73%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]